PolarityTE (PTEIQ) Competitors

$0.07
+0.05 (+251.26%)
(As of 05/1/2024 ET)

PTEIQ vs. SPRC, NMTR, GRI, BTTX, SXTC, SMFL, ADTX, MOTS, OBSV, and AMPE

Should you be buying PolarityTE stock or one of its competitors? The main competitors of PolarityTE include SciSparc (SPRC), 9 Meters Biopharma (NMTR), GRI Bio (GRI), Better Therapeutics (BTTX), China SXT Pharmaceuticals (SXTC), Smart for Life (SMFL), Aditxt (ADTX), Motus GI (MOTS), ObsEva (OBSV), and Ampio Pharmaceuticals (AMPE). These companies are all part of the "medical" sector.

PolarityTE vs.

PolarityTE (NASDAQ:PTEIQ) and SciSparc (NASDAQ:SPRC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PolarityTE
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
SciSparc
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

PolarityTE has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, SciSparc has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

11.8% of PolarityTE shares are held by institutional investors. Comparatively, 25.1% of SciSparc shares are held by institutional investors. 5.4% of PolarityTE shares are held by insiders. Comparatively, 1.5% of SciSparc shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, SciSparc had 2 more articles in the media than PolarityTE. MarketBeat recorded 2 mentions for SciSparc and 0 mentions for PolarityTE. PolarityTE's average media sentiment score of 0.00 beat SciSparc's score of -0.14 indicating that PolarityTE is being referred to more favorably in the media.

Company Overall Sentiment
PolarityTE Neutral
SciSparc Neutral

SciSparc's return on equity of 0.00% beat PolarityTE's return on equity.

Company Net Margins Return on Equity Return on Assets
PolarityTEN/A -106.08% -76.91%
SciSparc N/A N/A N/A

SciSparc received 2 more outperform votes than PolarityTE when rated by MarketBeat users.

CompanyUnderperformOutperform
PolarityTEN/AN/A
SciSparcOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

SciSparc has higher revenue and earnings than PolarityTE.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PolarityTE$810K0.18-$7.83M-$3.28-0.01
SciSparc$2.88M0.34-$5.12MN/AN/A

Summary

SciSparc beats PolarityTE on 8 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTEIQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTEIQ vs. The Competition

MetricPolarityTEBiotechnology IndustryMedical SectorNASDAQ Exchange
Market Cap$149,000.00$249.82M$4.88B$7.43B
Dividend YieldN/A3.48%2.85%3.95%
P/E Ratio-0.01241.26214.4416.88
Price / Sales0.1812,290.662,398.4186.80
Price / CashN/A11.2846.5635.50
Price / Book0.015.744.744.26
Net Income-$7.83M-$35.18M$102.47M$213.95M
7 Day PerformanceN/A2.17%1.97%0.52%
1 Month PerformanceN/A-2.22%-5.43%-4.98%
1 Year PerformanceN/A-2.76%5.19%6.45%

PolarityTE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPRC
SciSparc
0 of 5 stars
$1.32
+4.8%
N/A-92.2%$933,000.00$2.88M0.003
NMTR
9 Meters Biopharma
0 of 5 stars
N/A$1.70
+∞
N/A$1.04MN/A-0.0210
GRI
GRI Bio
0.4921 of 5 stars
0.43
0.0%
N/AN/A$1.37MN/A-0.014News Coverage
Gap Up
BTTX
Better Therapeutics
0 of 5 stars
$0.01
flat
$6.00
+59,900.0%
-98.8%$499,000.00N/A-0.0154Upcoming Earnings
SXTC
China SXT Pharmaceuticals
0 of 5 stars
$1.05
+1.9%
N/A-85.9%$483,000.00$1.97M0.0078Negative News
SMFL
Smart for Life
0 of 5 stars
$4.05
+15.7%
N/A-98.4%$462,000.00$11.11M0.00145Stock Split
Gap Down
ADTX
Aditxt
1.1067 of 5 stars
$2.39
-5.5%
$61.00
+2,452.3%
-90.4%$574,000.00$640,000.000.0061Positive News
Gap Up
MOTS
Motus GI
1.6466 of 5 stars
$0.08
flat
$28.88
+35,548.1%
-99.4%$407,000.00$320,000.000.0015Upcoming Earnings
OBSV
ObsEva
0 of 5 stars
$0.01
flat
N/AN/A$390,000.00$20.11M-0.0148Gap Down
AMPE
Ampio Pharmaceuticals
0 of 5 stars
$0.32
-8.5%
N/A-92.1%$366,000.00N/A-0.036Analyst Report
Gap Down

Related Companies and Tools

This page (NASDAQ:PTEIQ) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners